Deterioration of previous acute lung injury during neutropenia recovery

Critical Care Medicine

Volumn 30, Issue 4, 2002, Pages 781-786

  Azoulay, Elie ^a,b   Darmon, Michael ^a   Delclaux, Christophe ^b,c   Fieux, Fabienne ^a   Bornstain, Caroline ^a   Moreau, Delphine ^a   Attalah, Habiba ^b   Le Gall, Jean Roger ^a   Schlemmer, Benoît ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Acute respiratory distress syndrome; Cancer patients; Granulocyte colony stimulating factor; Leukemia; Lymphoma; Mechanical ventilation; Myeloma; Neutropenia; Neutropenia recovery; Pneumonia; Solid tumors

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; METHOTREXATE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ARTICLE; CANCER PATIENT; CONVALESCENCE; CRITICAL ILLNESS; FEMALE; FRANCE; HIGH RISK PATIENT; HUMAN; LEUKEMIA; LEUKOCYTE COUNT; LUNG INJURY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOMA; NEUTROPENIA; NEUTROPHIL; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SOLID TUMOR; TEACHING HOSPITAL;

EID: 0036218527     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200204000-00010     Document Type: Article

References (45)

1. Outcomes of critically ill cancer patients in a university hospital setting
2. Changing use of intensive care for hematological patients: The example of multiple myeloma
3. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
4. Multicenter outcome study of cancer patients admitted to the intensive care unit: A probability of mortality model
5. Cardiac toxicity 4 to 20 years after completing anthracycline therapy
6. Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts
7. Tumour microembolism presenting as "primary pulmonary hypertension"
8. Pulmonary lymphangitic carcinomatosis: CT and pathologic findings
9. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
10. Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies
11. Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids
12. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: Survey in Japan 1991-96
13. Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury
14. Recombinant G-CSF and the interstitial pneumonia during MACOP-B therapy in two cases of non-Hodgkin's lymphoma
15. Risks of rhG-CSF treatment in drug-induced agranulocytosis
16. The adult respiratory distress syndrome during the recovery of the neutrophil level after autologous bone marrow transplantation
17. Invasive aspergillosis in neutropenic patients: Rapid neutrophil recovery is a risk factor for severe pulmonary complications
18. Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support
19. APACHE - Acute physiology and chronic health evaluation: A physiologically based classification system
20. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study
21. High incidence of silent aspiration in elderly patients with community-acquired pneumonia
22. The importance of assessing the fit of logistic regression models: A case study
23. Adult respiratory distress syndrome in neutropenic patients
24. Occurrence of the adult respiratory distress syndrome in neutropenic patients
25. Adult respiratory distress syndrome in patients with severe neutropenia
26. Adult respiratory distress syndrome and sepsis
27. Gram-negative sepsis and the adult respiratory distress syndrome
28. Respiratory mechanics and lung morphometry in severe pancreatitis-associated acute lung injury in rats
29. Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease
30. Pulmonary infection in the compromised host: Part I
31. Neutrophils and the adult respiratory distress syndrome
32. Interstitial pneumonia in patients treated with VACOP-B therapy for malignant lymphoma
33. Chemotactic activity of recombinant human granulocyte colony-stimulating factor
34. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production
35. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia
36. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
37. Neutrophils released from the bone marrow by granulocyte colony-stimulating factor sequester in lung microvessels but are slow to migrate
38. Alveolar macrophage function in a canine model of endotoxin-induced lung injury
39. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: Prognostic indicators
40. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis
41. Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels
42. Polymorphonuclear leukocyte transit times in bone marrow during streptococcal pneumonia
43. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence-based guidelines
44. Noninvasive continuous positive airway pressure in neutropenic patients with acute respiratory failure requiring intensive care unit admission
45. Improved survival in cancer patients requiring mechanical ventilation: Impact of noninvasive mechanical ventilation